by Brenda Baletti, Ph.D., Childrens Health Defense:
A new study of the COVID-19 mRNA vaccine in mice found that lipid nanoparticles containing the spike protein dispersed to major vital organs, including the heart. Scientists say this type of research should have been done before the COVID-19 vaccines were rolled out to the global population.
Lipid nanoparticles (LNPs), used to deliver the mRNA in the COVID-19 vaccine to the body’s cells, don’t remain in the injection site — they circulate throughout the entire body and reach vital organs, including the heart, according to a new paper published in Nature Biotechnology.
TRUTH LIVES on at https://sgtreport.tv/
The findings “suggest a potential mechanism by which LNP-based mRNA vaccines could contribute to the reported cardiac complications,” including myocarditis, the study authors wrote.
Now published in one of the top scientific journals, the study’s findings contradict claims by public health officials and scientists during the COVID-19 vaccine rollouts that the LNPs were safe because they traveled only to specific targeted sites in the body.
The authors said there is no existing adequate technology to trace where nanocarriers such as LNPs end up in the body after they are administered via intramuscular injection — especially for medication like vaccines, which contain low doses of the particles.
In this study, authors developed an experimental technology to trace where different carriers of nanoparticles, including LNPs, end up in the body after intramuscular injection. They tested the technology in mice.
The researchers found that even at extremely low doses, LNPs carrying the SARS-CoV-2 spike protein mRNA reached vital organs. It reached heart tissue and caused cellular or tissue changes.
“COVID-19 mRNA injection LNPs systemically circulate and are taken up into vital organ systems resulting in body-wide toxic Spike protein production,” epidemiologist and McCullough Foundation administrator Nicolas Hulscher wrote on Substack.
According to Children’s Health Defense Senior Scientist Karl Jablonowski, the common misconception early in the COVID-19 vaccine rollout was that the LNP “stays in the muscle cells.”
This idea was perpetuated by major publications, like Science and Open Forum Infectious Diseases — a journal funded in part by the Centers for Disease Control and Prevention and Pfizer — even though Pfizer’s own study showed that after just 8 hours, a mere 22% of the initially injected LNPs remain at the site of injection, 18% migrated to the liver and 1% migrated to the spleen.
“This paper is an excellent example of how false that statement was, finding intramuscularly injected LNPs in the heart, liver, kidney, spleen, head, and ‘all analyzed lymph nodes,’” Jablonowski said.
Read More @ ChildrensHealthDefense.org
